Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 1
2008 3
2009 3
2010 3
2011 1
2012 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Immunotherapeutic and immunoregulatory drugs in haematologic malignancies.
Pangalis GA, Kyrtsonis MC, Vassilakopoulos TP, Dimopoulou MN, Siakantaris MP, Emmanouilides C, Doufexis D, Sahanas S, Kontopidou FN, Kalpadakis C, Angelopoulou MK, Dimitriadou EM, Kokoris SI, Panayiotidis P. Pangalis GA, et al. Among authors: doufexis d. Curr Top Med Chem. 2006;6(16):1657-86. doi: 10.2174/156802606778194235. Curr Top Med Chem. 2006. PMID: 17017950 Review.
Observational Study of Clinical Practice in Patients with Pancreatic Adenocarcinoma in Greece.
Papaxoinis G, Athanasiadis A, Sgouros J, Visvikis A, Drizou M, Kontopodis E, Koumarianou A, Stojanovska S, Aravantinos G, Korantzis I, Ioannou A, Varthalitis I, Doufexis D, Nikolaou M, Lypas G, Bompolaki I, Christopoulou A, Liontos M, Tsoukalas N, Mauri D, Xenidis N, Katsaounis P, Oikonomopoulos G, Boukovinas I. Papaxoinis G, et al. Among authors: doufexis d. J Oncol. 2020 Sep 19;2020:5304516. doi: 10.1155/2020/5304516. eCollection 2020. J Oncol. 2020. PMID: 33014051 Free PMC article.
Bevacizumab therapy may contribute to irradiation deferral in patients with breast cancer and with central nervous system metastases: findings of a case series.
Kountourakis P, Dokou A, Kardara E, Kaltsas S, Doufexis D, Tzovaras A, Mourgela S, Ardavanis A. Kountourakis P, et al. Among authors: doufexis d. Clin Breast Cancer. 2012 Aug;12(4):282-6. doi: 10.1016/j.clbc.2012.04.002. Epub 2012 May 19. Clin Breast Cancer. 2012. PMID: 22609269 No abstract available.
A phase I trial of adoptive transfer of allogeneic natural killer cells in patients with advanced non-small cell lung cancer.
Iliopoulou EG, Kountourakis P, Karamouzis MV, Doufexis D, Ardavanis A, Baxevanis CN, Rigatos G, Papamichail M, Perez SA. Iliopoulou EG, et al. Among authors: doufexis d. Cancer Immunol Immunother. 2010 Dec;59(12):1781-9. doi: 10.1007/s00262-010-0904-3. Epub 2010 Aug 12. Cancer Immunol Immunother. 2010. PMID: 20703455 Clinical Trial.
Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer.
Kountourakis P, Missitzis I, Doufexis D, Zobolas V, Pissakas G, Arnogiannaki N, Maliou S, Sotiropoulou A, Ardavanis A. Kountourakis P, et al. Among authors: doufexis d. J Cancer Res Clin Oncol. 2011 Feb;137(2):221-8. doi: 10.1007/s00432-010-0878-8. Epub 2010 Apr 13. J Cancer Res Clin Oncol. 2011. PMID: 20387073 Clinical Trial.
12 results